Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

shutterstock_138095450

Japan’s Oncolys invests £3m in adenovirus firm Unleash Immuno Oncolytics

February 20, 2018 Manufacturing and Production, Research and Development, Sales and Marketing Oncolys, Unleash Immuno Oncolytics, pharma

Unleash Immuno Oncolytics, a US firm focusing on the development of viral biologics in the treatment of cancer, has attracted …
News
lilly_entrance_web

Lilly dumps Hanmi’s rheumatoid arthritis med

February 20, 2018 Manufacturing and Production, Sales and Marketing Eli Lilly, arthritis, hanmi, pharma

Eli Lilly and Hanmi signed an exclusive licensing and collaboration agreement to develop the Bruton’s tyrosine kinase (BTK) inhibitor, HM71224, …
News
img_9530_resized

Patient experience: Living with multiple myeloma

February 19, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, feature, mutiple myeloma, patient experience, pharma

Pharmafocus talks to John Ellwood about the challenges of being diagnosed with multiple myeloma and how having a strong support …
Feature
fda_building

Apricus shares sink after failed erectile dysfunction application

February 19, 2018 Sales and Marketing Apricus, biotech, drugs, pharma, pharmaceutical

Apricus Biosciences had a lot riding on its application to the FDA for its erectile dysfunction cream, Vitaros, with the …
News
janssen_latest_logo_on_sign

Janssen’s Tremfya shows long-term efficacy in moderate to severe plaque psoriasis

February 19, 2018 Research and Development, Sales and Marketing Janssen, Tremfyam guselkumab, pharma, plaque psoriasis, psoriasis

Janssen has unveiled new Phase 3 trial data for its IL-23 inhibitor Tremfya (guselkumab), demonstrating that the drug was able …
News
celgene_1_02

Celgene reveals strong P3 Otezla data in rare inflammatory condition

February 19, 2018 Research and Development, Sales and Marketing Behçet's disease, Celgene, apremilast, otezla, pharma

Celgene has lifted the curtain on strong new Phase 3 data for its phosphodiesterase 4 (PDE4) inhibitor Otezla (apremilast) in …
News
gavel

Long-running, $2.5bn lawsuit swings in Gilead’s favour

February 19, 2018 Sales and Marketing Gilead, MSD, biotech, drugs, harvoni, pharma, pharmaceutical, sovaldi

The fate of pharma company’s profits and losses largely rests on product approvals and the sales team behind them but, …
News
astrazeneca_sign_sky

AZ’s Imfinzi seals blockbuster lung cancer market with FDA nod

February 19, 2018 Sales and Marketing AstraZeneca, Imfinzi, biotech, drugs, pharma, pharmaceutical

AstraZeneca’s immunotherapy, Imfinzi, arrived to the industry as a failure – there were big hopes resting on the company’s Mystic …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

February 16, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's disease, Roche, Top 10 news, Top ten news, Trump, biotech, drugs, pharma, pharmaceutical

Another week is finished and it’s been a disastrous one for research into a potential treatment for Alzheimer’s disease. Two of …
News

Roche boosts cancer efforts with $1.9 billion buyout of Flatiron Health

February 16, 2018 Medical Communications, Sales and Marketing Cancer, Flatiron health, Roche, acquisition, oncology, pharma

Roche has announced it is to acquire privately held healthcare and technology firm Flatiron Health for $1.9 billion to leverage …
News
stem-cell-163711_960_720

Silicon Valley-backed Celgene spin-off launches with $250m

February 16, 2018 Medical Communications, Sales and Marketing Celgene, Celularity, biotech, drugs, pharma, pharmaceutical

Biotechs are known for getting off the ground early with serious levels of financing, often based more on the acumen …
News
celltrion1

Celltrion’s Herceptin biosimilar seals EU approval

February 15, 2018 Sales and Marketing EU, Europe, Herceptin, Herzuma, celltrion, pharma

Herzuma, Celltrion’s biosimilar version of Roche/Genentech’s blockbuster immunotherapy Herceptin, has been awarded approval from the European Commission, the company has …
News
jj

J&J’s apalutamide scores snap FDA approval in castration-resistant prostate cancer subgroup

February 15, 2018 Sales and Marketing Cancer, Erleada, FDA, J&J, JJ, Johsnon & Johnson, apalutamide, pharma, prostate cancer

Johnson & Johnson has announced that its androgen receptor inhibitor apalutamide, now branded as Erleada, has received approval from the …
News

Astellas scoops up Universal Cells for $102.5m

February 15, 2018 Sales and Marketing Astellas, Universal Cells, biotech, drugs, pharma, pharmaceutical

Astellas Pharma had only signed an exclusive licensing deal with Universal Cells back in October for the co-development of a …
News

Bill & Melinda Gates Foundation shows faith in CureVac

February 14, 2018 Research and Development, Sales and Marketing Bill & Melinda Gates foundation, biotech, drugs, influenza, pharma, pharmaceutical

The Bill & Melina Gates Foundation had already invested $52 million in CureVac, back in 2015, and has now doubled …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025